This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Parisi A, et al. First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience. Clinical and Translational Oncology 22: 158-162, No. 1, Jan 2020. Available from: URL: http://doi.org/10.1007/s12094-019-02122-x